// AST – IMS - [DMinute_ROS]

As Gilead Sciences (GILD) Share Price Rose, Peak Asset Management Has Increased Its Position by $318,290; As Harley Davidson (HOG) Share Value Rose, Landscape Capital Management Boosted Holding by $3.24 Million

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Peak Asset Management Llc increased its stake in Gilead Sciences Inc (GILD) by 5.64% based on its latest 2018Q2 regulatory filing with the SEC. Peak Asset Management Llc bought 4,547 shares as the company’s stock rose 3.76% with the market. The hedge fund held 85,145 shares of the health care company at the end of 2018Q2, valued at $6.03 million, up from 80,598 at the end of the previous reported quarter. Peak Asset Management Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $89.97B market cap company. The stock decreased 1.85% or $1.31 during the last trading session, reaching $69.55. About 9.92M shares traded or 42.61% up from the average. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 12.47% since December 5, 2017 and is downtrending. It has underperformed by 28.09% the S&P500. Some Historical GILD News: 07/05/2018 – AbbVie’s Mavyret Falls After 1-Wk Rise, Epclusa Advances: Hep-C; 21/03/2018 – STAT Plus: Gilead patent for its Sovaldi hepatitis C drug is rejected in Ukraine; 12/03/2018 – Gilead Sciences Names Andrew Cheng Chief Medical Officer; 02/05/2018 – Gilead Slides as Street Looks for an End to Falling Sales; 05/03/2018 – GLAXOSMITHKLINE PLC – VIIV HEALTHCARE ANNOUNCES POSITIVE NEW DOLUTEGRAVIR DATA FOR TREATMENT OF PEOPLE LIVING WITH HIV CO-INFECTED WITH TUBERCULOSIS; 13/04/2018 – Gilead TAF Sales Rise 2%, HIV Combo Pills Gain 3%; 15/05/2018 – GILEAD SCIENCES – U.S. FDA HAS APPROVED ONCE-DAILY ORAL TRUVADA TO REDUCE RISK OF SEXUALLY ACQUIRED HIV-1 IN AT-RISK ADOLESCENTS; 19/04/2018 – Good news for $GLPG $GILD $ABBV is that FDA sees thrombosis as a unique issue with $INCY $LLY baricitinib and not seen with other JAKi; 30/04/2018 – GILEAD & VERILY REPORT SCIENTIFIC PACT; 11/05/2018 – Gilead Stockholders Approve Shareholder Proposal That Board Take Steps to Permit Stockholder Action by Written Consent

Landscape Capital Management Llc increased its stake in Harley Davidson Inc (HOG) by 61.23% based on its latest 2018Q2 regulatory filing with the SEC. Landscape Capital Management Llc bought 77,194 shares as the company’s stock rose 0.41% with the market. The hedge fund held 203,273 shares of the consumer non-durables company at the end of 2018Q2, valued at $8.55M, up from 126,079 at the end of the previous reported quarter. Landscape Capital Management Llc who had been investing in Harley Davidson Inc for a number of months, seems to be bullish on the $6.75B market cap company. The stock decreased 3.53% or $1.53 during the last trading session, reaching $41.86. About 4.63M shares traded or 89.26% up from the average. Harley-Davidson, Inc. (NYSE:HOG) has declined 6.40% since December 5, 2017 and is downtrending. It has underperformed by 22.02% the S&P500. Some Historical HOG News: 10/05/2018 – HARLEY-DAVIDSON INC HOG.N SETS QUARTERLY CASH DIVIDEND OF $0.37/SHR; 12/03/2018 – Harley-Davidson Honored for Research Contributions at 2018 MDA Clinical Conference; 05/03/2018 – “Seeing Caterpillar and Harley-Davidson trade higher tells me that traders think this will end diplomatically,” says one strategist; 24/04/2018 – HARLEY-DAVIDSON – REFINING PLANS AND IN SUMMER INTENDS TO REVEAL SIGNIFICANT ADDITIONAL STEPS TO IMPROVE PERFORMANCE AND VALUE CREATION THROUGH 2022; 24/04/2018 – Harley-Davidson 1Q Adj EPS $1.24; 30/05/2018 – Harley-Davidson And G-III Apparel Partner For Apparel In Asia — MarketWatch; 24/04/2018 – HARLEY-DAVIDSON REITERATES 2018 MOTORCYCLE SHIPMENTS GUIDANCE; 24/04/2018 – HARLEY-DAVIDSON 1Q MOTORCYCLE/PRODUCTS REV. $1.36B, EST. $1.24B; 24/04/2018 – Harley-Davidson Sees 2018 Capital Expenditures $250M-$270M; 24/04/2018 – HARLEY-DAVIDSON – PLAN TO INVEST ABOUT $75 MLN OF CAPITAL AND EXPECT ANNUAL ONGOING CASH SAVINGS OF BETWEEN $65 MLN TO $75 MLN AFTER 2020 – CONF CALL

Among 33 analysts covering Gilead Sciences (NASDAQ:GILD), 22 have Buy rating, 0 Sell and 11 Hold. Therefore 67% are positive. Gilead Sciences had 139 analyst reports since July 29, 2015 according to SRatingsIntel. Jefferies maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Tuesday, March 15. Jefferies has “Hold” rating and $97 target. Jefferies reinitiated it with “Hold” rating and $80 target in Tuesday, July 11 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by BMO Capital Markets on Monday, August 28. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Market Perform” rating given on Thursday, October 5 by Leerink Swann. The rating was downgraded by Robert W. Baird to “Neutral” on Thursday, July 26. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Overweight” rating by Barclays Capital on Tuesday, March 6. Jefferies maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, October 27 with “Hold” rating. Credit Suisse maintained the stock with “Buy” rating in Monday, August 28 report. The rating was maintained by BMO Capital Markets with “Hold” on Tuesday, January 2. Piper Jaffray initiated it with “Buy” rating and $8500 target in Wednesday, May 30 report.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Nasdaq.com which released: “Gilead Sciences : China Approves Descovy For Treatment Of HIV-1 Infection – Nasdaq” on December 04, 2018, also Seekingalpha.com with their article: “CAR-T Cells In The Real World – Seeking Alpha” published on November 23, 2018, Nasdaq.com published: “Gilead’s HIV Franchise, CAR T Therapy Likely to Propel Growth – Nasdaq” on November 26, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “Ebola clinical trial to begin in DRC – Seeking Alpha” published on November 13, 2018 as well as Nasdaq.com‘s news article titled: “Aileron Inks Collaboration Deal With Pfizer for Cancer Combo – Nasdaq” with publication date: November 28, 2018.

Since July 2, 2018, it had 0 buys, and 4 sales for $14.63 million activity.

Investors sentiment decreased to 0.75 in 2018 Q2. Its down 0.13, from 0.88 in 2018Q1. It dropped, as 75 investors sold GILD shares while 532 reduced holdings. 89 funds opened positions while 366 raised stakes. 977.84 million shares or 0.14% more from 976.44 million shares in 2018Q1 were reported. Boston Family Office Limited Liability Co invested in 0.9% or 111,762 shares. Aviance Ptnrs Limited Liability invested in 11,453 shares or 0.23% of the stock. Millennium Management Ltd Liability Com reported 1.53 million shares. Lazard Asset Management Ltd Liability Corporation, New York-based fund reported 979,882 shares. Noesis Cap Mangement holds 93,105 shares or 2.42% of its portfolio. Aldebaran Inc invested in 15,980 shares or 0.78% of the stock. Atwood And Palmer reported 2.14% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). First Midwest Bancorporation Tru Division holds 37,144 shares or 0.37% of its portfolio. Valley Natl Advisers stated it has 0.04% in Gilead Sciences, Inc. (NASDAQ:GILD). Boston Prtn reported 8.29 million shares or 0.7% of all its holdings. Acropolis Inv Mngmt Ltd Liability Company reported 2,300 shares. Clear Harbor Asset Mgmt Lc owns 11,246 shares or 0.15% of their US portfolio. Cannell Peter B owns 49,875 shares. Alpha Cubed Invests Limited Liability Com accumulated 27,089 shares or 0.25% of the stock. Hartford Financial Inc, a Connecticut-based fund reported 140 shares.

Landscape Capital Management Llc, which manages about $258.27 million and $1.20 billion US Long portfolio, decreased its stake in Brandywine Rlty Tr (NYSE:BDN) by 26,200 shares to 42,400 shares, valued at $716,000 in 2018Q2, according to the filing. It also reduced its holding in Bjs Restaurants Inc (NASDAQ:BJRI) by 109,748 shares in the quarter, leaving it with 97,852 shares, and cut its stake in Blackrock Mun 2030 Tar Term (BTT).

Since August 6, 2018, it had 0 insider purchases, and 2 insider sales for $616,781 activity. Shares for $69,513 were sold by ZEITZ JOCHEN on Monday, August 6.

Investors sentiment increased to 1.14 in 2018 Q2. Its up 0.36, from 0.78 in 2018Q1. It improved, as 31 investors sold HOG shares while 121 reduced holdings. 61 funds opened positions while 113 raised stakes. 137.89 million shares or 10.26% less from 153.65 million shares in 2018Q1 were reported. Macquarie Gp Limited invested 0% of its portfolio in Harley-Davidson, Inc. (NYSE:HOG). North Star Invest Management stated it has 0% of its portfolio in Harley-Davidson, Inc. (NYSE:HOG). Rafferty Asset Mngmt Limited Liability Company accumulated 0.08% or 124,373 shares. Chevy Chase Tru Hldgs accumulated 0.03% or 139,994 shares. Centurylink Inv Mgmt reported 33,364 shares or 0.54% of all its holdings. Natixis Advisors Lp invested in 56,248 shares or 0.02% of the stock. Findlay Park Ltd Liability Partnership invested in 3.20 million shares or 1.29% of the stock. Amica Mutual Ins Company accumulated 0.04% or 7,168 shares. Rodgers Brothers holds 9,000 shares or 0.12% of its portfolio. Qs Llc, a New York-based fund reported 14,839 shares. Destination Wealth Mgmt invested 0% in Harley-Davidson, Inc. (NYSE:HOG). 240,683 were accumulated by Amundi Pioneer Asset. Pggm Invs holds 136,255 shares or 0.03% of its portfolio. Dubuque Comml Bank And has invested 0% in Harley-Davidson, Inc. (NYSE:HOG). Lsv Asset Mngmt invested 0.26% in Harley-Davidson, Inc. (NYSE:HOG).

Harley-Davidson, Inc. (NYSE:HOG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.